Document Page: First | Prev | Next | All | Image | This Release | Search
File: 970101_sep96_decls30_0005.txt
Subject: ANTHRAX 04 OCT 90
Unit: VAR. BUMED
Parent Organization: BUMED
Box ID: BX303902
Folder Title: NERVE AGENTS - A BRIEF REFERENCE
Document Number: 3
Folder Seq #: 13
UNCLASSIFIED
day incubation period the patient suffers from non-specific upper
respiratory tract symptoms. After several days he develops
st-idor, respiratory distress, and subcutaneous chest wall edema.
At this point death occurs within 24 hours. In biowarfare this
sequence of events is likely to be shortened considerably ley an
unnaturally large number organisms. The characteristic chest
radiograph shows a widened mediastinum often associated with
pleural effusions (usually bloody) but no parenchymal infiltrate.
Once recognized patients should be intubated. Although high
doses of intravenous penicillin is the drug of choice for
naturally-acquired pulmonary anthrax, in biowarfare ciprofloxacin
1000 mg bid Is recommended as it is relatively easy to induce
penicillin resistance in the laboratory. Asymptomatic
individuals should be given 500 mg bid as prophylaxis as long as
the threat persists. Because death will continue to occur
despite appropriate treatment, ideally vaccination of all
personnel at risk with at least two 0.5 nl injection of vaccine
given 2 weeks apart should be administered. However current
stocks of this vaccine are not known.
Botulism
Clostridium botulinum produces a neurotoxin which blocks
neurotransmission by preventing the release of acetylcholine at
choline--gic synapses. This toxir. can be delivered by aerosol.
Symptoms and signs occur within 3-36 hours of exposure. Motor
abnormalities are prominent and occur early with cronial and
bulbar verues, (EOM paralysis, diplopia, ptosis, dysarthria,
dysphonia, dysphagia) affected first followed by flaccid
and respiratory muscles. Chol.energic
effects include meioses, decreased salivation, and bladder and GI
dysmotility. In the biowarfare setting it is necessary to
UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 7 f:/Week-44/BX303902/NERVE AGENTS - A BRIEF REFERENCE/anthrax 04 oct 90:12249609070331
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-44
Box ID = BX303902
Unit = VAR. BUMED
Parent Organization = BUMED
Folder Title = NERVE AGENTS - A BRIEF REFERENCE
Folder Seq # = 13
Subject = ANTHRAX 04 OCT 90
Document Seq # = 3
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 24-DEC-1996